1 Stock To Buy, 1 To Dump When Markets Open: DocuSign, Nikola

 | Nov 29, 2020 07:00AM ET

Stocks on Wall Street ended in positive territory on Friday, with the S&P 500 and NASDAQ closing at new record highs amid ongoing optimism over COVID-19 vaccine progress.

Friday’s gains added to the market’s surge this month. The Dow is on pace for its biggest monthly gain since January 1987, up 12.9% in November. The S&P 500 and NASDAQ climbed 11.3% and 11.9%, respectively over the same period.

Investors will be watching fresh COVID-19 vaccine headlines as well as developments surrounding the pandemic in the week ahead, amid worries the record surge in cases will lead to further restrictions.

Below we highlight one stock that has proven it can successfully navigate the current market swings and another likely to see additional losses in the coming days:

h2 Stock To Buy: DocuSign/h2

DocuSign (NASDAQ:DOCU)—widely considered the leader in the e-signature market—has thrived this year as the COVID-19 pandemic and the shift to a work-from-home environment created soaring demand for its services.

Shares of the San Francisco, California-based software-as-a-service company have more than doubled in 2020, jumping 206%, easily outpacing the benchmark S&P 500’s 12.6% rise over the same timeframe.

DOCU stock closed at $226.87 on Friday, giving the leading provider of electronic signature technology a valuation of roughly $41.6 billion.